Accounting for Government Grants

Companies receiving non-repayable cash, equipment, or other assets from government agencies face an accounting puzzle: is the grant income, a reduction in expense, or a deferred liability? Accounting for government grants differs sharply between IFRS (IAS 20) and US GAAP, with IFRS requiring grants to be deferred and recognised over the period the company performs the underlying act (e.g., hiring workers or investing in equipment), while US GAAP has no unified standard and defers to ASC 405 or industry-specific guidance.

IFRS IAS 20 requires systematic deferral and recognition

Under IAS 20, a government grant is a transfer of resources to an entity, contingent on compliance with specified conditions. The framework distinguishes between grants on operating activities (subsidies for wages, R&D, training) and grants related to assets (equipment, buildings, infrastructure). The core principle: recognise grant income over the periods in which the entity earns the grant by performing the underlying act.

If a government offers a manufacturing company €1 million to build a factory in a region, the €1 million is recorded as deferred revenue (a liability) at inception. As the company incurs capital expenditures and brings the factory online, it recognises a portion of the deferred revenue as income each period. The income-recognition period typically aligns with the depreciation period of the asset. If the factory has a 20-year useful life and the grant is tied to the factory, the company recognises €50,000 per year as income.

For operating grants—subsidies for hiring workers, conducting R&D, or purchasing supplies—the timing is linked to the activity. A government grant to cover R&D labour costs is recognised as income when the labour is incurred. If the government guarantees €500,000 per year for three years to fund a research programme, the company recognises €500,000 as income each year (offset against the R&D expense that created it).

The effect is elegant: the grant never inflates reported operating income in a single lump sum; instead, it smooths income over the period the company benefits from the grant or performs the required activity. This prevents artificial spikes in reported earnings from non-recurring government support.

Conditions and performance obligations determine deferral periods

A critical detail: does the grant have conditions? Most grants do. A government might offer cash for capital investment on condition the company maintains operations in the region for five years, or provides training to disadvantaged workers. If the company meets the condition, the grant is nonrefundable and is deferred and recognised systematically. If the company breaches the condition (e.g., relocates operations), the grant is clawed back and must be repaid.

Under IFRS, a grant with conditions is treated as a performance obligation until the condition is met. The company defers the entire grant as a liability and recognises it as income only as the condition is satisfied. For a grant contingent on maintaining employment, the company recognises a portion as income each month or year that employment is maintained; if employment is cut, the remaining deferred grant is not recognised.

Unconditional grants—money the government provides with no strings attached—are rare. Even “unconditional” cash often comes with implicit conditions (the recipient must be in good standing, not be under investigation, etc.). IAS 20 requires that conditions be identified and assessed, but in practice most grants are deferred over a conservative period to reflect the underlying benefit period.

US GAAP has no single standard; tax credits are often routed to tax expense

The US does not have a single accounting standard for government grants that mirrors IAS 20. Instead, guidance is scattered across ASC 405 (credits, allowances, and other adjustments), industry-specific guidance (e.g., for utilities, financial institutions), and the tax code via ASC 740 (income taxes).

For cash subsidies (e.g., a state grant to hire workers), companies often choose between two approaches: (1) reduce the associated expense (like wage expense) as the grant is earned, or (2) record the grant as revenue or income. The choice depends on the industry, the nature of the grant, and materiality. A manufacturer receiving a capital grant to build a facility might reduce the cost basis of the equipment and recognise the benefit over depreciation, or might defer the grant and recognise it as income. Auditors and companies negotiated these choices individually, creating inconsistency.

For tax credits (e.g., the R&D tax credit, the investment tax credit, or the Employee Retention Credit), US GAAP is clearer. Tax credits are recorded in the income tax line under ASC 740. A company that claims a $1 million R&D tax credit reduces its income tax expense by $1 million (though the credit is subject to limitations and carry-forward rules). The company does not treat the credit as operating income.

This routing is intuitive: tax credits are incentives embedded in the tax code, so they logically flow through the tax expense line. However, it also means the company’s operating results are unaffected by the tax credit; the benefit shows only in lower taxes. For a company with high effective tax rates, this can obscure the magnitude of government support.

Practical differences create comparability issues

The divergence between IAS 20 (required deferral and systematic recognition) and US GAAP (flexible, no unified rule) means that a US company and an IFRS-reporting international competitor might account for identical grants very differently. The US company might record a €1 million grant as immediate income, boosting operating earnings. The international company would defer it and recognise it systematically, smoothing income over years.

Investors comparing the two companies would see different earnings quality and profitability metrics. The IFRS company appears more conservative; the US company’s reported income is volatile relative to the grant receipt. For multinational companies, this creates reconciliation work: auditors must restate IFRS numbers to US GAAP equivalents or vice versa.

The FASB has proposed converging US GAAP to IAS 20, but the process is slow. In the interim, preparers and auditors use judgment, often aligning with IAS 20 principles even under US GAAP, to produce consistent accounting across jurisdictions.

Repayment obligations and contingent liabilities

Grants subject to clawback—the government can demand repayment if conditions are breached—create a liability separate from the deferred-revenue liability. If a company receives a grant to hire 50 workers and must repay it if employment falls below 40 within five years, the company records the grant and simultaneously assesses the probability of repayment.

If repayment is remote (unlikely), the contingent liability is disclosed in footnotes. If repayment is reasonably possible or probable, a liability is accrued under ASC 450 (contingencies) or IFRS 3 (provisions). This can cause earnings to be adjusted retrospectively if conditions are later breached: the company reverses the recognised income and records a loss.

Large grants with repayment risks—such as COVID-19 relief funds (Paycheck Protection Program loans, enhanced unemployment benefits) that were later found to be conditionally repayable—created post-grant accounting challenges. Companies had to restate financial statements when clawback became probable.

Disclosure requirements reveal grant magnitude

Both IFRS and US GAAP require disclosure of grants received, the purpose, and the accounting method. Under IAS 20, companies disclose the amount of grants recognised as income in the period and the balance of deferred grants on the balance sheet. This transparency allows investors to understand how much government support is underlying reported earnings.

US GAAP disclosure is less standardised but typically includes the amount, purpose, and any repayment conditions in footnotes. For tax credits, the amount of unused credits and carry-forward periods are disclosed on the tax footnote under ASC 740.

Government grants grow in strategic importance

In recent years, government grants and tax incentives have proliferated. Subsidies for renewable energy, electric vehicle manufacturing, semiconductor fabrication, and regional development are increasingly material to corporate profitability. For a company building a solar farm with a $100 million investment, a $20 million investment tax credit can cut the effective cost basis dramatically. A semiconductor foundry receiving a $5 billion CHIPS Act grant can defer it over the life of the new fab (perhaps 15–20 years), smoothing the boost to earnings.

As grants grow, accounting treatment becomes more consequential. A company adopting IFRS and deferring a $5 billion grant over 15 years recognises $333 million as income per year. A comparable US GAAP company might record the grant upfront or route it differently, creating apparent earnings divergence that reflects accounting choice, not economic reality.

See also